Surgery and OncologySurgery and OncologyХирургия и онкология2949-5857Publishing House ABV Press23610.17650/2220-3478-2017-7-4-64-70CASE REPORTКЛИНИЧЕСКОЕ НАБЛЮДЕНИЕSUCCESSFUL TREATMENT OF A SOLITARY FIBROUS TUMOR IN THE SMALL PELVIS: A CASE REPORTУСПЕШНЫЙ СЛУЧАЙ ЛЕЧЕНИЯ ПАЦИЕНТА С СОЛИТАРНОЙ ФИБРОЗНОЙ ОПУХОЛЬЮ МАЛОГО ТАЗА (КЛИНИЧЕСКОЕ НАБЛЮДЕНИЕ)PolynovskiyA. V.ПолыновскийА. В.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478

Андрей Владимирович Полыновский.

115478 Москва, Каширское шоссе, 23

polynovskiy@gmail.comRasulovA. O.РасуловА. О.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478

115478 Москва, Каширское шоссе, 23

KuzmichevD. V.КузьмичевД. В.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478

115478 Москва, Каширское шоссе, 23

TrofimovI. A.ТрофимовИ. А.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478

115478 Москва, Каширское шоссе, 23

KozlovN. A.КозловН. А.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478

115478 Москва, Каширское шоссе, 23

MadyarovZh. M.МадьяровЖ. М.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478

115478 Москва, Каширское шоссе, 23

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России260220187464702802201828022018Copyright ©; 2018, Polynovskiy A.V., Rasulov A.O., Kuzmichev D.V., Trofimov I.A., Kozlov N.A., Madyarov Z.M.Copyright ©; 2018, Полыновский А.В., Расулов А.О., Кузьмичев Д.В., Трофимов И.А., Козлов Н.А., Мадьяров Ж.М.2018Polynovskiy A.V., Rasulov A.O., Kuzmichev D.V., Trofimov I.A., Kozlov N.A., Madyarov Z.M.Полыновский А.В., Расулов А.О., Кузьмичев Д.В., Трофимов И.А., Козлов Н.А., Мадьяров Ж.М.https://creativecommons.org/licenses/by/4.0https://onco-surgery.info/jour/article/view/236

In the article we describe our experience treating a patient with a giant solitary fibrous tumor of the small pelvis. Since the tumor was highly vascularized, the patient underwent preoperative embolization of the vessels perfusing the tumor to reduce the risk of intraoperative blood loss.

В клиническом наблюдении представлен опыт лечения пациента с гигантской солитарной фиброзной опухолью малого таза. Учитывая высокую васкуляризацию новообразования, для снижения риска интраоперационной кровопотери больному перед оперативным вмешательством выполнена эмболизация питающих опухоль сосудов.

solitary fibrous tumorhemangiopericytomasmall pelvisembolizationсолитарная фиброзная опухольгемангиоперицитомамалый тазэмболизация1. Park M.S., Araujo D.M. New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors. Curr Opin Oncol 2009;21(4):327–31. DOI: 10.1097/CCO.0b013e32832c9532.Park M.S., Araujo D.M. New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors. Curr Opin Oncol 2009;21(4):327–31. DOI: 10.1097/CCO.0b013e32832c9532.2. Hasegawa T., Matsuno Y., Shimoda T. et al. Extrathoracic solitary fibrous tumors: their histological variability and potentially aggressive behavior. Hum Pathol 1999;30(12):1464–73. DOI: 10.1016/S0046-8177(99)90169-7.Hasegawa T., Matsuno Y., Shimoda T. et al. Extrathoracic solitary fibrous tumors: their histological variability and potentially aggressive behavior. Hum Pathol 1999;30(12):1464–73. DOI: 10.1016/S0046-8177(99)90169-7.3. Wang H., Chen P., Zhao W. et al. Clinicopathological findings in a case series of abdominopelvic solitary fibrous tumors. Oncol Lett 2014;7(4):1067–72. DOI: 10.3892/ol.2014.1872.Wang H., Chen P., Zhao W. et al. Clinicopathological findings in a case series of abdominopelvic solitary fibrous tumors. Oncol Lett 2014;7(4):1067–72. DOI: 10.3892/ol.2014.1872.4. Katsuno H., Maeda K., Hanai T. et al. Trans-sacral resection of a solitary fibrous tumor in the pelvis: report of a case. Surg Today 2011;41(11):1548–51. DOI: 10.1007/s00595-010-4535-2.Katsuno H., Maeda K., Hanai T. et al. Trans-sacral resection of a solitary fibrous tumor in the pelvis: report of a case. Surg Today 2011;41(11):1548–51. DOI: 10.1007/s00595-010-4535-2.5. Robinson L.A. Solitary fibrous tumor of the pleura. Cancer Control 2006;13(4):264–9. PMID: 17075563.Robinson L.A. Solitary fibrous tumor of the pleura. Cancer Control 2006;13(4):264–9. PMID: 17075563.6. Klemperer P., Rabin C. Primary neoplasms of the pleura. A report of five cases. Am J Ind Med 1992;22(1):1–31. PMID: 1415270.Klemperer P., Rabin C. Primary neoplasms of the pleura. A report of five cases. Am J Ind Med 1992;22(1):1–31. PMID: 1415270.7. Fletcher C.D.M. World Health Organization Classification of tumours of soft tissue and bone. 4th edn. Eds.: C.D.M. Fletcher, J.A. Bridge, P.C.W. Hogendoorn, F. Mertens. Lyon: IARC Press, 2013. 80 p.Fletcher C.D.M. World Health Organization Classification of tumours of soft tissue and bone. 4th edn. Eds.: C.D.M. Fletcher, J.A. Bridge, P.C.W. Hogendoorn, F. Mertens. Lyon: IARC Press, 2013. 80 p.8. Li X.M, Reng J., Zhou P. et al. Solitary fibrous tumors in abdomen and pelvis: imaging characteristics and radiologicpathologic correlation. World J Gastroenterol 2014;20(17):5066–73. DOI: 10.3748/wjg.v20.i17.5066.Li X.M, Reng J., Zhou P. et al. Solitary fibrous tumors in abdomen and pelvis: imaging characteristics and radiologicpathologic correlation. World J Gastroenterol 2014;20(17):5066–73. DOI: 10.3748/wjg.v20.i17.5066.9. Kanthan R., Torkian B. Recurrent solitary fibrous tumor of the pleura with malignant transformation. Arch Pathol Lab Med 2004;128(4):460–62. DOI: 10.1043/1543-2165(2004)128<460:RSFTOT>2.0.CO;2.Kanthan R., Torkian B. Recurrent solitary fibrous tumor of the pleura with malignant transformation. Arch Pathol Lab Med 2004;128(4):460–62. DOI: 10.1043/1543-2165(2004)128<460:RSFTOT>2.0.CO;2.10. Torres-Olivera F.J., Vargas M.T., TorresGomez F.J. et al. Cytogenetic, fluorescence in situ hybridization, and immunohistochemistry studies in a malignant pleural solitary fibrous tumor. Cancer Genet Cytogenet 2009;189(2):122–6. DOI: 10.1016/j.cancergencyto.2008.11.004.Torres-Olivera F.J., Vargas M.T., TorresGomez F.J. et al. Cytogenetic, fluorescence in situ hybridization, and immunohistochemistry studies in a malignant pleural solitary fibrous tumor. Cancer Genet Cytogenet 2009;189(2):122–6. DOI: 10.1016/j.cancergencyto.2008.11.004.11. Hanau C.A., Miettinen M. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol 1995;26(4):440–49. PMID: 7705824.Hanau C.A., Miettinen M. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol 1995;26(4):440–49. PMID: 7705824.12. Yokoi T., Tsuzuki T., Yatabe Y. et al. Solitary fibrous tumor: significance of p53 and CD34 immunoreactivity in its malignant transformation. Histopathology 1998;32(5):423–32. PMID: 9639117.Yokoi T., Tsuzuki T., Yatabe Y. et al. Solitary fibrous tumor: significance of p53 and CD34 immunoreactivity in its malignant transformation. Histopathology 1998;32(5):423–32. PMID: 9639117.13. Gold J.S., Antonescu C.R., Hajdu C. et al. Clinicopathologic correlates of solitary fibrous tumors. Cancer 2002;94(4):1057–68. PMID: 11920476.Gold J.S., Antonescu C.R., Hajdu C. et al. Clinicopathologic correlates of solitary fibrous tumors. Cancer 2002;94(4):1057–68. PMID: 11920476.14. Collini P., Negri T., Barisella M. et al. High-grade sarcomatous overgrowth in solitary fibrous tumor: a clinicopathological study of 10 cases. Am J Surg Pathol 2012;36(8):1202–15. DOI: 10.1097/PAS.0b013e31825748f0.Collini P., Negri T., Barisella M. et al. High-grade sarcomatous overgrowth in solitary fibrous tumor: a clinicopathological study of 10 cases. Am J Surg Pathol 2012;36(8):1202–15. DOI: 10.1097/PAS.0b013e31825748f0.15. Stacchiotti S., Negri T., Palassini E. et al. Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response. Mol Cancer Therapy 2010;9(5):1286–97. DOI: 10.1158/1535-7163.MCT-09-1205.Stacchiotti S., Negri T., Palassini E. et al. Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response. Mol Cancer Therapy 2010;9(5):1286–97. DOI: 10.1158/1535-7163.MCT-09-1205.16. Wushou A., Jiang Y.Z., Liu Y.R. et al. The demographic features, clinicopathologic characteristics, treatment outcome and disease-specific prognostic factors of solitary fibrous tumor: a population-based analysis. Oncotarget 2015;6(39):41875–83. DOI: 10.18632/oncotarget.6174.Wushou A., Jiang Y.Z., Liu Y.R. et al. The demographic features, clinicopathologic characteristics, treatment outcome and disease-specific prognostic factors of solitary fibrous tumor: a population-based analysis. Oncotarget 2015;6(39):41875–83. DOI: 10.18632/oncotarget.6174.17. Spitz F.R., Bouvet M., Pisters P.W. et al. Hemangiopericytoma: a 20-year singleinstitution experience. Ann Surg Oncol 1998;5(4):350–5. PMID: 9641457.Spitz F.R., Bouvet M., Pisters P.W. et al. Hemangiopericytoma: a 20-year singleinstitution experience. Ann Surg Oncol 1998;5(4):350–5. PMID: 9641457.18. Espat N.J., Lewis J.J., Leung D. et al. Conventional hemangiopericytoma: modern analysis of outcome. Cancer 2002;95(8):1746–51. DOI: 10.1002/cncr.10867.Espat N.J., Lewis J.J., Leung D. et al. Conventional hemangiopericytoma: modern analysis of outcome. Cancer 2002;95(8):1746–51. DOI: 10.1002/cncr.10867.19. DeVito N., Henderson E., Han G. et al. Clinical characteristics and outcomes for solitary fibrous tumor (SFT): a single center experience. PLoS One 2015;10(10):e0140362. DOI: 10.1371/journal.pone.0140362.DeVito N., Henderson E., Han G. et al. Clinical characteristics and outcomes for solitary fibrous tumor (SFT): a single center experience. PLoS One 2015;10(10):e0140362. DOI: 10.1371/journal.pone.0140362.20. Ballo M.T., Zagars G.K., Cormier J.N. et al. Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2004;58(5):1461–7. DOI: 10.1016/j.ijrobp.2003.09.079.Ballo M.T., Zagars G.K., Cormier J.N. et al. Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2004;58(5):1461–7. DOI: 10.1016/j.ijrobp.2003.09.079.21. Kawamura S., Nakamura T., Oya T. et al. Advanced malignant solitary fibrous tumor in pelvis responding to radiation therapy. Pathol Int 2007;57(4):213–8. DOI: 10.1111/j.1440-1827.2007.02083.x.Kawamura S., Nakamura T., Oya T. et al. Advanced malignant solitary fibrous tumor in pelvis responding to radiation therapy. Pathol Int 2007;57(4):213–8. DOI: 10.1111/j.1440-1827.2007.02083.x.22. Saynak M., Bayir-Angin G., Kocak Z. et al. Recurrent solitary fibrous tumor of the pleura: significant response to radiotherapy. Med Oncol 2010;27(1): 45–8. DOI: 10.1007/s12032-009-9168-1.Saynak M., Bayir-Angin G., Kocak Z. et al. Recurrent solitary fibrous tumor of the pleura: significant response to radiotherapy. Med Oncol 2010;27(1): 45–8. DOI: 10.1007/s12032-009-9168-1.23. Dietrich C.G., Roeb E., Breuer E. et al. Solitary fibrous thoracic wall tumor. Progression with percutaneous radiotherapy. Deutsche Medizinische Wochenschrift 2001;126(1–2):12–5. DOI: 10.1055/s-2001-9884.Dietrich C.G., Roeb E., Breuer E. et al. Solitary fibrous thoracic wall tumor. Progression with percutaneous radiotherapy. Deutsche Medizinische Wochenschrift 2001;126(1–2):12–5. DOI: 10.1055/s-2001-9884.24. Domont J., Massard C., Lassau N. et al Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma/ solitary fibrous tumor. Invest New Drugs 2010;28(2):199–202. DOI: 10.1007/s10637-009-9249-1.Domont J., Massard C., Lassau N. et al Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma/ solitary fibrous tumor. Invest New Drugs 2010;28(2):199–202. DOI: 10.1007/s10637-009-9249-1.25. George S., Merriam P., Maki R.G. et al. Multicenter phase II trial of sunitinib in the treatment of non-gastrointestinal stromal tumor sarcomas. J Clin Oncol 2009;27(19):3154–60. DOI: 10.1200/JCO.2008.20.9890.George S., Merriam P., Maki R.G. et al. Multicenter phase II trial of sunitinib in the treatment of non-gastrointestinal stromal tumor sarcomas. J Clin Oncol 2009;27(19):3154–60. DOI: 10.1200/JCO.2008.20.9890.26. Mulamalla K., Truskinovsky A.M., Dudek A.Z., Mulamalla K. Rare case of hemangiopericytoma responds to sunitinib. Transl Res 2008;151(3):129–33. DOI: 10.1016/j.trsl.2007.12.007.Mulamalla K., Truskinovsky A.M., Dudek A.Z., Mulamalla K. Rare case of hemangiopericytoma responds to sunitinib. Transl Res 2008;151(3):129–33. DOI: 10.1016/j.trsl.2007.12.007.27. Park M.S., Patel S.R., Ludwig J.A. et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer 2011;117(21):4939–47. DOI: 10.1002/cncr.26098.Park M.S., Patel S.R., Ludwig J.A. et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer 2011;117(21):4939–47. DOI: 10.1002/cncr.26098.28. Stacchiotti S., Negri T., Libertini M. et al. Sunitinib in solitary fibrous tumor (SFT). Ann Oncol 2012;23(12):3171–9. DOI: 10.1093/annonc/mds143.Stacchiotti S., Negri T., Libertini M. et al. Sunitinib in solitary fibrous tumor (SFT). Ann Oncol 2012;23(12):3171–9. DOI: 10.1093/annonc/mds143.29. Stacchiotti S. Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour. Eur J Cancer 2014;50(17):3021–8. DOI: 10.1016/j.ejca.2014.09.004.Stacchiotti S. Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour. Eur J Cancer 2014;50(17):3021–8. DOI: 10.1016/j.ejca.2014.09.004.30. Sleijfer S., Ray-Coquard I., Papai Z. et al. Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organization for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). J Clin Oncol 2009;27(19):3126–32. DOI: 10.1200/JCO.2008.21.3223.Sleijfer S., Ray-Coquard I., Papai Z. et al. Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organization for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). J Clin Oncol 2009;27(19):3126–32. DOI: 10.1200/JCO.2008.21.3223.31. Van der Graaf W.T., Blay J.Y., Chawla S.P. et al. EORTC Soft Tissue and Bone Sarcoma Group; PALETTE study group. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomized, double-blind, placebo-controlled phase 3 trial. Lancet 2012;379(9829):1879–86. DOI: 10.1016/S0140-6736(12)60651-5.Van der Graaf W.T., Blay J.Y., Chawla S.P. et al. EORTC Soft Tissue and Bone Sarcoma Group; PALETTE study group. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomized, double-blind, placebo-controlled phase 3 trial. Lancet 2012;379(9829):1879–86. DOI: 10.1016/S0140-6736(12)60651-5.32. Spagnuolo R.D., Brich S., Bozzi F. et al. Sunitinib-induced morphofunctional changes and drug effectiveness in malignant solitary fibrous tumors. Oncotarget 2016;7(29):45015–26. DOI: 10.18632/oncotarget.7523.Spagnuolo R.D., Brich S., Bozzi F. et al. Sunitinib-induced morphofunctional changes and drug effectiveness in malignant solitary fibrous tumors. Oncotarget 2016;7(29):45015–26. DOI: 10.18632/oncotarget.7523.33. Quek R., Wang Q., Morgan J.A. et al. Combination mTOR and IGF-1R inhibition: phase I trial of everolimus and figitumumab in patients with advanced sarcomas and other solid tumors. Clin Cancer Res 2011;17(4):871–9. DOI: 10.1158/1078-0432.CCR-10-2621.Quek R., Wang Q., Morgan J.A. et al. Combination mTOR and IGF-1R inhibition: phase I trial of everolimus and figitumumab in patients with advanced sarcomas and other solid tumors. Clin Cancer Res 2011;17(4):871–9. DOI: 10.1158/1078-0432.CCR-10-2621.34. Schwartz G.K., Tap W.D., Qin L.X. et al. Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicenter, open-label, phase 2 trial. Lancet Oncol 2013;14(4):371–82. DOI: 10.1016/S1470-2045(13)70049-4.Schwartz G.K., Tap W.D., Qin L.X. et al. Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicenter, open-label, phase 2 trial. Lancet Oncol 2013;14(4):371–82. DOI: 10.1016/S1470-2045(13)70049-4.35. Kulshreshtha P., Kannan N., Bhardwaj R. et al. Primary mediastinal hemangiopericytoma treated with preoperative embolization and surgery. Ann Thorac Surg 2014;97(1):335–8. DOI: 10.1016/j.athoracsur.2013.04.128.Kulshreshtha P., Kannan N., Bhardwaj R. et al. Primary mediastinal hemangiopericytoma treated with preoperative embolization and surgery. Ann Thorac Surg 2014;97(1):335–8. DOI: 10.1016/j.athoracsur.2013.04.128.36. Aydemir B., Celik S., Okay T. et al. Intrathoracic giant solitary fibrous tumor. Am J Case Rep 2013;14:91–3. DOI: 10.12659/AJCR.883867.Aydemir B., Celik S., Okay T. et al. Intrathoracic giant solitary fibrous tumor. Am J Case Rep 2013;14:91–3. DOI: 10.12659/AJCR.883867.37. Santillan A., Zink W., Lavi E. et al. Endovascular embolization of cervical hemangiopericytoma with Onyx-18: case report and review of the literature. J Neurointerv Surg 2011;3(3):304–7. DOI: 10.1136/jnis.2010.003756.Santillan A., Zink W., Lavi E. et al. Endovascular embolization of cervical hemangiopericytoma with Onyx-18: case report and review of the literature. J Neurointerv Surg 2011;3(3):304–7. DOI: 10.1136/jnis.2010.003756.38. Kim M.Y., Jeon S., Choi S.D. et al. A case of solitary fibrous tumor in the pelvis presenting massive hemorrhage during surgery. Obstet Gynecol Sci 2015;58(1):73–6. DOI: 10.5468/ogs.2015.58.1.73.Kim M.Y., Jeon S., Choi S.D. et al. A case of solitary fibrous tumor in the pelvis presenting massive hemorrhage during surgery. Obstet Gynecol Sci 2015;58(1):73–6. DOI: 10.5468/ogs.2015.58.1.73.39. Enzinger F.M., Smith B.H. Hemangiopericytoma. An analysis of 106 cases. Hum Pathol 1976;7(1):61–82. DOI: 10.1016/S0046-8177(76)80006-8.Enzinger F.M., Smith B.H. Hemangiopericytoma. An analysis of 106 cases. Hum Pathol 1976;7(1):61–82. DOI: 10.1016/S0046-8177(76)80006-8.